June is Alzheimer’s and Brain Awareness Month, and to highlight it, we’re featuring a nonprofit that developed a science-backed method of increasing empathy for those with certain neurological conditions. Designed for caregivers, health care professionals, and family members, the Virtual Dementia Tour is an eight-minute simulation that alters participants’ sensory perceptions — so they can experience firsthand what dementia is like. Click below to learn about how it helps and see footage of people trying it out.
Ally Mauch
Associate Editor
Today’s Pick
Harold Hoch/MediaNews Group/Reading Eagle via Getty Images
A Unique Simulation Builds Empathy by Allowing People to Experience Dementia Symptoms
More than 7 million Americans are living with Alzheimer’s disease, and while most adults are familiar with the outward signs, the inner experience is in large part a mystery to those without the condition.
In a market that shifts by the week, investing in stability is a smart move — and biotech offers just that. The highs and lows of Wall Street have little effect on scientific advancement, so while the market swings, Cytonics is focused on building breakthrough osteoarthritis treatment with the potential to reverse joint degradation.
But Cytonics isn’t following the typical playbook. Instead of chasing venture dollars or Big Pharma buyouts, the company is backed by everyday investors like you. With 25 patents, a de-risked platform technology, and a successful Phase 1 trial, Cytonics is entering their next stage of growth — and you could be part of it. Over 6,000 shareholders have already invested through the company’s Reg A+ offering. Now it’s your turn to help reshape the future of medicine while owning a piece of it.
